
Swedish fintech company Klarna has announced plans to introduce randomised drug testing for its employees as part of a wider effort to bolster workplace security. The move comes as the company prepares for its initial public offering (IPO) in the United States.
According to Business Insider, Klarna informed employees of the new policy via an internal Slack message. The testing will be conducted by an external supplier to ensure compliance with local laws and industry standards.